Cargando…
Strategies to improve γδTCRs engineered T-cell therapies for the treatment of solid malignancies
Autores principales: | Meringa, A. D., Hernández-López, P., Cleven, A., de Witte, M., Straetemans, T., Kuball, J., Beringer, D. X., Sebestyen, Z. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333927/ https://www.ncbi.nlm.nih.gov/pubmed/37441064 http://dx.doi.org/10.3389/fimmu.2023.1159337 |
Ejemplares similares
-
GMP-Grade Manufacturing of T Cells Engineered to Express a Defined γδTCR
por: Straetemans, Trudy, et al.
Publicado: (2018) -
Adding Help to an HLA-A*24:02 Tumor-Reactive γδTCR Increases Tumor Control
por: Johanna, Inez, et al.
Publicado: (2021) -
Cancer Immunotherapy Using γδT Cells: Dealing with Diversity
por: Scheper, Wouter, et al.
Publicado: (2014) -
Orchestrating an immune response against cancer with engineered immune cells expressing αβTCRs, CARs, and innate immune receptors: an immunological and regulatory challenge
por: de Witte, Moniek A., et al.
Publicado: (2015) -
TCR-engineered T cells: A model of inducible TCR expression to dissect the interrelationship between two TCRs
por: Reuß, Simone, et al.
Publicado: (2014)